Consensus Takeda Pharmaceutical Company Limited NYSE

Stocks

TAK

US8740602052

Pharmaceuticals

Real-time Estimate Cboe BZX Other stock markets 14:23:55 2026-07-10 EDT			5-day change	1st Jan Change
16.56 ^USD	-0.27%		-1.97%	+6.21%

07-08	Takeda Pharmaceutical Completes Share Issuance, Disposal Under Incentive Plan	MT
07-02	Asian Equities Traded in the US as American Depositary Receipts Surge in Thursday Trading	MT

Evolution of the Average Target: Takeda Pharmaceutical Company Limited

Evolution of the Target Price: Takeda Pharmaceutical Company Limited

Changes in Analyst Recommendations: Takeda Pharmaceutical Company Limited

f04dbcfb3efad28.bjC2ICgg6ptkMeIDFb8xPpbz-cjPPYSCKiIlVM2kRIA.KAjbRltwru8HUNtuccZkYcWbzaWrR8jHX2xjJYTKG8cjau54Z3SQ7zFjhQ~998ab457dfe38d0f900bee9ec5eeb656

Analysts' recommendations: Takeda Pharmaceutical Company Limited

03-30	Alumis' Drug 'Very Positive' for Treatment of Psoriasis, Systemic Lupus Erythematosus, Oppenheimer Says	MT
01-30	Jefferies Adjusts Takeda Pharmaceutical's Price Target to 5,700 Yen From 5,100 Yen, Keeps at Buy	MT
11-11	Neurocrine Biosciences' Depressive Disorder Drug Fails to Meet Primary Goal in Phase 2 Study	MT
25-09-26	Alkermes' Stock Dip on Narcolepsy Data Seen as Buying Opportunity, RBC Says	MT
25-08-20	Veeva Systems Q2 Results Likely In-Line to Better, Maintain H2 Outlook, Truist Says	MT
25-05-09	Jefferies Adjusts Takeda Pharmaceutical's Price Target to 5,100 Yen From 5,500 Yen, Keeps at Buy	MT
25-05-06	Jefferies Adjusts Takeda Pharmaceutical Company's Price Target to 5,500 Yen From 5,000 Yen, Keeps at Buy	MT
24-08-12	Jefferies Adjusts Takeda Pharmaceutical's Price Target to 5,000 Yen From 4,800 Yen, Keeps at Buy	MT
24-07-31	Jefferies Adjusts Takeda Pharmaceutical's Price Target to 4,800 Yen From 5,600 Yen, Keeps at Buy	MT
24-02-13	Jefferies Adjusts Takeda Pharmaceutical's Price Target to 5,600 Yen From 5,200 Yen, Keeps at Buy	MT
23-10-03	Jefferies Adjusts Takeda Pharmaceutical’s Price Target to 5,200 Yen From 5,300 Yen, Keeps at Buy	MT
23-09-22	Jefferies Adjusts Takeda Pharmaceutical’s Price Target to 5,300 Yen From 5,100 Yen, Keeps at Buy	MT
23-05-31	Jefferies Adjusts Takeda Pharmaceutical’s Price Target to 5,100 Yen From 5,000 Yen, Keeps at Buy	MT
23-05-16	TD Cowen Adjusts Price Target on Takeda Pharmaceutical to $20 From $30, Maintains Outperform Rating	MT
23-04-04	TD Cowen Adjusts Price Target on Takeda Pharmaceutical to $30 From $24, Keeps Outperform Rating	MT
23-03-16	BofA Securities Upgrades Takeda Pharmaceutical to Buy From Neutral, Price Target $20	MT
23-03-06	Jefferies Adjusts Takeda Pharmaceutical’s Price Target to 5,000 Yen From 4,600 Yen, Keeps at Buy	MT
22-08-01	Jefferies Downgrades Takeda Pharmaceutical to Hold From Buy	MT
22-07-19	Cowen Upgrades Takeda Pharmaceutical to Outperform From Market Perform	MT
21-10-07	TAKEDA PHARMACEUTICAL : Morgan Stanley Downgrades Takeda Pharmaceutical to Equal-weight From Overweight	MT
17-09-08	BAYER : Germany's Merck hires JP Morgan to sell consumer health	RE

More recommendations

Sector Comparison:

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	ELI LILLY AND COMPANY					+1.93%
	JOHNSON & JOHNSON					-0.2%
	ABBVIE INC.					+3.82%
	ROCHE HOLDING AG					+7.07%
	ASTRAZENECA PLC					+20.73%
	NOVARTIS AG					-0.27%
	NOVO NORDISK A/S					-1.01%
	AMGEN INC.					-2.19%
	GILEAD SCIENCES, INC.					+17.4%
	Average					+5.25%
	Weighted average by Cap.					+3.85%